logo
Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)

Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)

National Post2 days ago

Article content
BEIJING & NANJING, China — Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ('Biocytogen', HKEX: 02315) and Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. ('NJCTTQ') announced that NTB003 (formerly BCG009), a co-developed injectable drug candidate, has received the Investigational New Drug (IND) approval from the National Medical Products Administration (NMPA). The approved indication is Thyroid Eye Disease (TED).
Article content
About NTB003 Injection
Article content
NTB003 is a second-generation fully human anti-IGF-1R monoclonal antibody co-developed by Biocytogen and Nanjing Chia Tai Tianqing. Antibody discovery and optimization were completed by Biocytogen using its proprietary RenMab™ fully human antibody discovery platform, while Nanjing Chia Tai Tianqing was responsible for CMC process development, GLP-compliant toxicology studies, and IND application. Compared with first-generation approved anti-IGF-1R therapeutics, NTB003 demonstrates enhanced molecular affinity, improved druggability, and an extended half-life. In vitro studies have shown that NTB003 exerts potent signal-blocking activity and effectively inhibits the release of hyaluronic acid (HA), indicating strong potential for further clinical development.
Article content
Clinical studies of teprotumumab and other investigational anti-IGF-1R biologics have demonstrated that targeting IGF-1R can deliver significant clinical benefits. These agents have shown rapid onset of therapeutic response and favorable outcomes in reducing proptosis and diplopia, improving quality of life, and lowering clinical activity scores in patients with TED.
Article content
Nanjing Chia Tai Tianqing will lead the clinical development and commercialization of NTB003 in China, aiming to provide an improved therapeutic option for Chinese TED patients. Biocytogen will be responsible for the global out-licensing of the product outside China.
Article content
About Biocytogen
Article content
Biocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice ® (RenMab ™ / RenLite ® / RenNano ® / RenTCR-mimic™ ) platforms for fully human monoclonal/bispecific/multispecific antibody discovery, bispecific antibody-drug conjugate discovery, nanobody discovery and TCR-mimic antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >1,000,000 fully human antibody sequences against over 1000 targets for worldwide collaboration. As of December 31, 2024, approximately 200 therapeutic antibody and multiple clinical asset co-development/out-licensing/transfer agreements and over 50 target-nominated RenMice ® licensing projects have been established around the globe, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA (Boston, San Francisco, San Diego), and Germany (Heidelberg). For more information, please visit http://en.biocytogen.com.cn.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Biocytogen Contacts
Article content
Article content
Article content

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

U.S., Chinese officials to meet in London next week for new round of trade talks
U.S., Chinese officials to meet in London next week for new round of trade talks

CTV News

time6 hours ago

  • CTV News

U.S., Chinese officials to meet in London next week for new round of trade talks

President Donald Trump speaks during a meeting with the Fraternal Order of Police in the State Dinning Room of the White House, Thursday, June 5, 2025, in Washington. (AP Photo/Alex Brandon) WASHINGTON — Senior U.S. administration officials will meet with a Chinese delegation on Monday in London for the next round of trade negotiations between Washington and Beijing, U.S. President Donald Trump said Friday. The meeting comes after a phone call between Trump and Chinese leader Xi Jinping on Thursday, which the U.S. president described as a 'very positive' conversation as the two countries attempt to break an impasse over tariffs and global supplies of rare earth minerals. Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick and U.S. Trade Representative Jamieson Greer will represent the U.S. side in the trade talks. 'The meeting should go very well,' Trump wrote on his social media platform Friday afternoon. The conversation between Trump and Xi, who lead the world's two biggest economies, lasted about an hour and a half, according to the U.S. president. The Chinese foreign ministry has said Trump initiated the call. The ministry said Xi asked Trump to 'remove the negative measures' that the U.S. has taken against China. It also said that Trump said 'the U.S. loves to have Chinese students coming to study in America,' although his administration has vowed to revoke some of their visas. Article by Seung Min Kim.

While Bitcoin Hits a New Price Record, Critics Still Have These Warnings for Crypto Investors
While Bitcoin Hits a New Price Record, Critics Still Have These Warnings for Crypto Investors

Globe and Mail

time7 hours ago

  • Globe and Mail

While Bitcoin Hits a New Price Record, Critics Still Have These Warnings for Crypto Investors

Bitcoin (CRYPTO: BTC) may have hit a new all-time high of $112,000 in May, but it's not out of the woods quite yet. Already, Bitcoin has retreated back down to the $105,000 level, and there are some critics warning about a further decline in price. While the long-term outlook for Bitcoin might be bullish, there could be quite a bit of uncertainty and volatility over the second half of 2025. Here are three key factors keeping the Bitcoin skeptics up at night. Tariff and trade uncertainty As long as tariffs continue to dominate the headlines, they will continue to have a direct impact on how investors view the crypto market. As a result, it's been a see-saw year for Bitcoin. After hitting an all-time high in January, Bitcoin dropped as low as $75,000 after President Donald Trump announced the new Liberation Day tariffs on April 2. Bitcoin has subsequently recovered, but every week seems to bring some new twist or turn in the tariff debate. The newest factor is the worsening state of the trade negotiations involving the U.S. and China. At one time, it looked like some kind of trade deal might be worked out by mid-summer. Now, it looks like the two sides are further apart than ever. So how will Bitcoin investors react? If they view Bitcoin as a safe haven asset, they might move even more money into Bitcoin, thereby boosting its price. However, if they view Bitcoin as a risky and volatile digital asset, then they might sell off, just as they did in April. Unfinished business in Washington When President Trump came into office in January, the future looked very bright indeed for Bitcoin. New crypto legislation looked like it would be ready to sign soon, and crypto enthusiasts were excited about upcoming Bitcoin initiatives from the Trump White House. However, five months into the presidency, and there's still a lot of unfinished business. Take the Strategic Bitcoin Reserve, for example. Yes, Trump signed an executive order for its creation in March, but it delivered much less punch than many people expected. Most importantly, the executive order failed to outline how the government planned to buy Bitcoin in the future. As a result, investors are still waiting on some form of legislation, such as the BITCOIN Act proposed by Sen. Cynthia Lummis (R-Wyo.), that will precisely outline a mechanism for buying more Bitcoin. On top of all that, there are now questions swirling around the Trump family's connections to Bitcoin. At the very least, there appear to be potential conflicts of interest. For example, Donald Trump's media company -- Trump Media & Technology Group -- recently divulged plans to buy $2.5 billion worth of Bitcoin. And members of the Trump family now have interests in a variety of Bitcoin-related projects. The four-year Bitcoin cycle Historically, Bitcoin has followed a fairly predictable pattern of boom and bust. The four-year Bitcoin cycle starts with a period of quiet accumulation, followed by a period of rapid growth. This leads to a Bitcoin bubble filled with hype and speculation. After that comes the crash. For example, the 2020-2021 rally that saw Bitcoin hit a (then) all-time high of $69,000 was quickly followed by a disastrous market crash that saw it lose 65% of its value in 2022. And the same pattern may be happening again. If history is any guide, then the final phase of the Bitcoin cycle could be arriving soon. Thus, even if Bitcoin soars to $150,000 this year, it might have a hard time holding on to those gains heading into 2026. If you'd have waited until now to buy Bitcoin, you might be buying at or close to the top of the market. By the end of 2025, it might already be too late. Only a 22% chance of failure? The good news is that most Bitcoin investors are remarkably bullish these days. According to online prediction markets, Bitcoin only has a 22% chance of falling below the $70,000 price level, and only a 16% chance of falling below the $60,000 price level. Long gone are the days when people regularly prognosticated that Bitcoin could fall all the way to zero. That being said, investors still need to be aware of the risks of investing in Bitcoin. The price of Bitcoin never goes straight up. It is highly volatile, filled with many peaks and valleys. If you don't have firm convictions about Bitcoin, it's remarkably easy to buy high and sell low. When it comes to Bitcoin, it's best to keep a long-term perspective. Bitcoin has never been a tariff-proof, inflation-proof, or recession-proof asset. But over a long enough time horizon, it continues to be the top-performing asset in the world. The only catch is that you have to be willing to hold on to it, through good times and bad. Should you invest $1,000 in Bitcoin right now? Before you buy stock in Bitcoin, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bitcoin wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor 's total average return is789% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025

Premier Li: Development of China, Canada is opportunity, not threat
Premier Li: Development of China, Canada is opportunity, not threat

Canada Standard

time8 hours ago

  • Canada Standard

Premier Li: Development of China, Canada is opportunity, not threat

National flags of China (right) and Canada. /VCG Chinese Premier Li Qiang said on Friday that the development of China and Canada represents an opportunity, not a threat, to each other. "The two countries do not have fundamental conflicts of interest, but rather share a tradition of friendship and mutual benefit," Li told Canadian Prime Minister Mark Carney during a phone call. Li said that Canada was one of the first Western countries to establish diplomatic relations with the People's Republic of China, and the bilateral relationship was at the forefront of China's ties with Western nations for a long time. However, in recent years, the relationship has suffered serious difficulties due to unnecessary disruptions, he added. Li expressed hope that the Canadian side will work with China in the same direction, view China's development in an objective and rational way, and jointly promote prosperity for mutual success. China is willing to work with Canada, in the spirit of looking to the future, to promote the steady improvement of bilateral relations, bring them onto a track of sound and steady development, and strive for win-win cooperation, said Li. Looking ahead, there is enormous potential for China-Canada cooperation as the two economies are highly complementary, said Li, urging both sides to deepen cooperation in traditional areas, expand collaboration in emerging fields such as clean energy, climate change and scientific and technological innovation, and strengthen people-to-people as well as economic and trade exchanges. Li called on both governments to listen to their people, respond to their concerns, and do more to enhance bilateral friendly cooperation and increase mutual understanding and trust. China is willing to work with Canada, on the basis of equality and mutual respect, to seek and expand common ground while shelving and narrowing differences, strengthen exchanges and dialogue in various fields, and address each other's concerns appropriately, Li said. Noting that the current international situation is intertwined with turmoil, and unilateralism and protectionism are on the rise, Li said China is ready to work with Canada to jointly safeguard multilateralism and free trade, promote economic globalization and the multilateral trading system to develop in the right direction, and inject more stability into world peace and development. For his part, Carney said that Canada and China have a profound traditional friendship and China is Canada's second-largest trading partner. While bilateral relations have experienced some setbacks in recent years, he said, Canada is ready to restart its relationship with China. The Canadian side looks forward to resuming high-level exchanges and dialogue mechanisms in areas such as diplomacy and economic and trade with China, and strengthening pragmatic cooperation in trade, agriculture, energy and environmental protection, he added. In the face of the current international landscape, Canada is willing to enhance communication and coordination with China, jointly safeguard the international financial and trading system, and contribute to promoting global sustainable development, Carney said. (With input from Xinhua) Source: CGTN

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store